These 4 still overvalued stocks will fall another 25% in the next few weeks.
These 4 undervalued low-floater microcaps will gain an average of 25% within a month...DWCH $4.8, STRM $3, PRXM $1.12, AND BLUE $0.75.
DWCH, STRM, BLUE will have improved/strong earnings this month. BLUE on the 13th and DWCH as well as STRM on the 27th
DWCH will report strong 4Q and record FY 2007 on November 27. DWCH has improved its financial performance each of the last 4 quarters and expects this trend to continue.
Per analysts' estimates, and last CC comments, 4Q 2007 will be a near record quarter for DWCH capping a record year revenue-wise:
- 4Q 2007 Revenues est. $6.2M compared to $5.3M in 4Q 2006
- 4Q 4007 Net Income est. of 6c/share compared to a 10c/share loss in 4Q 2006
- FY 2007 Revenue est: $25M compared to $21M in 2006
- FY 2007 Net Income est. of 20c/share vs. a 10c/share loss in 2006
**** For FY 2008, DWCH is expected to produce revenues from $27M - $32M and net income from 30c/share to 40/c share ***
- DWCH has 50c/share cash and ZERO debt
- DWCH is trading at a P/S of about 1.0 compared to its peers trading close to 3.
STRM is expected to report a strong 2nd half of the year. With a market cap of less than $30M and a float of 5M - 6 monthsshares. STRM could easily double in the next 3 months.
STRM $3 is an important partner in GE Healthcare Centricity products for workflow and document management tools for medical systems. STRM provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, portal connectivity, optical character recognition (OCR) and interoperability for the healthcare sector.
STRM has a huge number of medical institutions as loyal customers: MD Anderson, St Luke's, Baylor, Methodist, Mayo Clinic, Albert Einstein institute and many other large medical system.
PRXM $1.12 is an under-the radar Wi-Fi/WiMax/Mesh play poised to achieve profitability due to significant moves to cut costs including R&D outsourcing to India and a significant increase in gross margins to about 50%
*** Cash of $12M (60s/share) and ZERO debt.
*** Market cap of $35M with about $80M in revenues!!
*** On a surprising announcement this week, PRXM decided to repurchase a total of over 3.5M shares at $1.7. These repurchases are expected to be completed by November 16, 2007. When completed, these transactions will reduce Proxim's outstanding shares by approximately 9.0% and its fully-diluted capitalization by approximately 11.3%.
BLUE $0.75, with only 3.5M shares on the float is starting to implement a $2.8M/year cost reduction program to increase profits to the 30 - 50c/share range. Blue's market cap is less than $20M
BLUE's Antik Denim and Taverniti have become recognized brands in both the United States and internationally, worn by such celebrities as Cameron Diaz, Jennifer Lopez and Paris Hilton. The Antik Denim signature designs of ornately decorated jeans with hand-wrought embroidery, patchwork pockets are the latest �must have� among Hollywood celebrities. The Antik Denim brand was featured on In Touch magazine as one of �Hollywood�s Must-have Denim.� Antik Denim, Taverniti, Faith Connexion and Yanuk brands have been seen on celebrities like Teri Hatcher, Hilary Duff, Jennifer Lopez, Jessica Simpson, Charlize Theron Kate Hudson and many more. Adding to the excitement have been fashion layouts in trend-setting publications such as Elle, Life & Style, Glamour, Marie Claire, Lucky, Bazaar, and Nylon.
ot - if you like great value microcaps, check out RBC Life Sciences, p/e of roughly 9 and sales growing 45% per year; ~ $20m mkt. cap, plus it's got a great story. It looks like an easy triple from current level of .92: